Turn Downtime Into Cash!
He's showing regular people how they can make a killing as traders right from their homes!
Click here to see how.
pixel

IMNM Insider Trading (Immunome)

Insider Ownership Percentage: 19.20%
Insider Buying (Last 12 Months): $2,301,461.07
Insider Selling (Last 12 Months): $0.00

Immunome Insider Trading History Chart

This chart shows the insider buying and selling history at Immunome by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Immunome Share Price & Price History

Current Price: $24.67
Price Change: Price Increase of +1.7 (7.40%)
As of 09/17/2021 05:00 PM ET

This chart shows the closing price history over time for IMNM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Turn Downtime Into Cash!
He's showing regular people how they can make a killing as traders right from their homes!
Click here to see how.
pixel

Immunome Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/13/2021Michael RappDirectorBuy25,962$19.96$518,201.52799,866View SEC Filing Icon  
9/9/2021Michael RappDirectorBuy30,450$18.19$553,885.50799,866View SEC Filing Icon  
5/26/2021Michael LefenfeldDirectorBuy1,335$19.03$25,405.0522,822View SEC Filing Icon  
5/25/2021Purnanand D. SarmaCEOBuy10,500$18.41$193,305.0010,500View SEC Filing Icon  
5/24/2021Michael LefenfeldDirectorBuy600$17.80$10,680.0046,726View SEC Filing Icon  
10/6/2020Michael RappDirectorBuy83,332$12.00$999,984.00555,554View SEC Filing Icon  
See Full Table
Insider Selling at Immunome?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Immunome and related companies.

SEC Filings (Institutional Ownership Changes) for Immunome (NASDAQ:IMNM)

20.12% of Immunome stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IMNM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Immunome Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/23/2021Morgan Stanley11,371$0.20M0.0%+9,375.8%0.096%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC36,670$0.63M0.0%N/A0.312%Search for SEC Filing on Google Icon
8/16/2021Royal Bank of Canada28,127$0.49M0.0%+8,271.1%0.239%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley11,371$0.20M0.0%+9,375.8%0.097%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC20,400$0.35M0.0%N/A0.174%Search for SEC Filing on Google Icon
8/13/2021Alpine Global Management LLC854,671$14.79M2.0%+7.4%7.269%Search for SEC Filing on Google Icon
8/13/2021Neuberger Berman Group LLC19,444$0.34M0.0%N/A0.165%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC39,529$0.68M0.0%-19.9%0.336%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.302,092$5.23M0.0%+95.9%2.569%Search for SEC Filing on Google Icon
8/12/2021Ergoteles LLC10,006$0.17M0.0%N/A0.085%Search for SEC Filing on Google Icon
8/9/2021Wealth Architects LLC11,201$0.19M0.0%N/A0.095%Search for SEC Filing on Google Icon
8/6/2021Magnus Financial Group LLC25,759$0.45M0.1%+75.9%0.219%Search for SEC Filing on Google Icon
7/31/2021Sterling Investment Advisors Ltd.21,627$0.37M0.1%N/A0.184%Search for SEC Filing on Google Icon
7/31/2021Ridgewood Investments LLC58,013$1M0.6%N/A0.493%Search for SEC Filing on Google Icon
5/18/2021Prentice Capital Management LP331,995$11.25M3.5%-20.3%2.824%Search for SEC Filing on Google Icon
5/14/2021O Shaughnessy Asset Management LLC1,599$54K0.0%N/A0.015%Search for SEC Filing on Google Icon
5/13/2021Alpine Global Management LLC795,709$26.96M2.6%+0.7%7.464%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp27,114$0.92M0.0%+7.2%0.254%Search for SEC Filing on Google Icon
5/12/2021Cerity Partners LLC110,327$3.74M0.1%-10.0%1.035%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC49,331$1.67M0.0%+225.0%0.463%Search for SEC Filing on Google Icon
5/11/2021New York State Common Retirement Fund3,650$0.12M0.0%-33.0%0.034%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.112,851$3.82M0.0%+57.3%1.059%Search for SEC Filing on Google Icon
5/5/2021Magnus Financial Group LLC14,648$0.50M0.1%N/A0.137%Search for SEC Filing on Google Icon
4/23/2021Strs Ohio1,400$47K0.0%N/A0.013%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.5,731$55K0.0%N/A0.054%Search for SEC Filing on Google Icon
2/12/2021Prentice Capital Management LP416,667$4.03M1.1%N/A3.952%Search for SEC Filing on Google Icon
2/12/2021Kepos Capital LP66,666$0.65M0.1%N/A0.632%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp25,287$0.25M0.0%N/A0.240%Search for SEC Filing on Google Icon
2/11/2021Cerity Partners LLC122,546$1.19M0.0%N/A1.162%Search for SEC Filing on Google Icon
2/8/2021New York State Common Retirement Fund5,450$53K0.0%N/A0.052%Search for SEC Filing on Google Icon
2/6/2021Granite Point Capital Management L.P.66,666$0.65M0.0%N/A0.632%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.71,752$0.70M0.0%N/A0.681%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Immunome logo
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.
Read More on Immunome

Today's Range

Now: $24.67
Low: $22.51
High: $24.99

50 Day Range

MA: $16.14
Low: $12.50
High: $24.67

52 Week Range

Now: $24.67
Low: $9.27
High: $63.78

Volume

427,050 shs

Average Volume

295,024 shs

Market Capitalization

$291.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Immunome?

Immunome's top insider shareholders include:
  1. Michael Rapp (Director)
  2. Michael Lefenfeld (Director)
  3. Purnanand D Sarma (CEO)

Who are the major institutional investors of Immunome?

Immunome's top institutional investors include:
  1. Alpine Global Management LLC — 7.27%
  2. Vanguard Group Inc. — 2.57%
  3. Ridgewood Investments LLC — 0.49%
  4. Geode Capital Management LLC — 0.34%
  5. Millennium Management LLC — 0.31%
  6. Royal Bank of Canada — 0.24%

Which institutional investors are selling Immunome stock?

During the previous quarter, IMNM stock was sold by these institutional investors:
  1. Geode Capital Management LLC

Which institutional investors are buying Immunome stock?

In the previous quarter, IMNM stock was acquired by institutional investors including:
  1. Vanguard Group Inc.
  2. Alpine Global Management LLC
  3. Ridgewood Investments LLC
  4. Millennium Management LLC
  5. Royal Bank of Canada
  6. Sterling Investment Advisors Ltd.
  7. Renaissance Technologies LLC
  8. Neuberger Berman Group LLC
Within the previous year, these company insiders have bought Immunome stock:
  1. Michael Rapp (Director)
  2. Michael Lefenfeld (Director)
  3. Purnanand D Sarma (CEO)
Turn Downtime Into Cash!
He's showing regular people how they can make a killing as traders right from their homes!
Click here to see how.
pixel